Rep. Eshoo Advances ARPA-H and Diversity in Clinical Trials Bills Through Committee
WASHINGTON, D.C. – Today Congresswoman Anna G. Eshoo (D-CA), Chairwoman of the Energy and Commerce Health Subcommittee, hailed Committee passage of her ARPA-H Act, bipartisan legislation to establish the Advanced Research Project Agency-Health as an independent agency within HHS. The Committee also passed key portions of Eshoo’s DEPICT Act, bipartisan legislation to increase diversity in clinical trials.
“Today, with an overwhelmingly bipartisan vote, we advanced my ARPA-H legislation to provide the new agency with the full authorities it needs to be successful from Day One, ensuring it will be a nimble, dynamic, and independent agency. This new agency will serve as a beacon of hope to the many Americans who for decades have urged Congress to do more to address diseases that are currently a death sentence, such as pancreatic cancer, Alzheimer’s disease, ALS, and glioblastoma,” said Eshoo. “I’m also proud that we advanced sections of my DEPICT Act which will ensure clinical trials include diverse and representative populations, making science fairer and more accurate.”
You can watch the full markup here.